SCHEMBL7225557

SCHEMBL7225557

O=C(N[C@@H]1C[C@H]2CC[C@@H]1N2)c1ccc(Oc2cccnc2)s1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC8A1 P32418 2/20 0.37
NAAA Q02083 1/20 0.36
BTK Q06187 5/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
CHRNB2 P17787 3/20 0.34
CHRNA7 P36544 3/20 0.34
CHRNA4 P43681 3/20 0.34
ABL1 P00519 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231264 0.88 CYP1A2 (0.32) SLC8A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL7225381 0.88 HTR3E (0.37) CHRNA7
SCHEMBL7231120 0.85 P2RY14 (0.38) BTKCHRNB2CHRNA4
SCHEMBL7225301 0.85 CCNC (0.37) CHRNB2CHRNA4
SCHEMBL7225892 0.84 CHRNB2 (0.39) CHRNB2CHRNA7CHRNA4
SCHEMBL7223531 0.83 CHRNB4 (0.40) CHRNA7
SCHEMBL7233323 0.83 ESR1 (0.37)
SCHEMBL7231868 0.82 SLC6A2 (0.41) EPHX2
SCHEMBL7231813 0.82 CHRNA7 (0.34) SLC8A1CHRNA7
SCHEMBL7226014 0.82 SLC6A2 (0.41) CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed